Circulation
-
Randomized Controlled Trial
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
The MOMENTUM 3 trial compares the centrifugal HeartMate 3 (HM3) with the axial HeartMate II (HMII) continuous-flow left ventricular assist system in patients with advanced heart failure, irrespective of the intended goal of therapy. The trial's 2-year clinical outcome (n=366) demonstrated superiority of the HM3 for the primary end point (survival free of a disabling stroke or reoperation to replace or remove a malfunctioning pump). This analysis evaluates health resource use and cost implications of the observed differences between the 2 devices while patients were enrolled in the trial. ⋯ URL: https://www.clinicaltrials.gov . Unique identifier: NCT02224755.